New blood thinner looking good; superior to Lovenox? – Bristol-Myers Squibb Co.’s and Pfizer Inc.’s experimental blood thinner prevented dangerous blood clots from forming after knee replacement surgery better than Sanofi-Aventis’s Lovenox in a European study. The company-funded trial, dubbed Advance-2, found patients given apixaban pills twice daily were 38 percent less likely to develop clots deep in the legs, in the lungs or die within two weeks than those given intravenous Lovenox starting before the operation. People in both groups had a similar risk of bleeding, a feared complication of blood-thinning medications. SA..more BMS is talking about 60 drugs in testing phase these days…
Eisai‘s sales to go down by more than half – Japan’s No.4 drugmaker, said it expects annual U.S. sales of its flagship Alzheimer’s drug Aricept to fall 60 percent in three years, hit by the expiration of the drug’s patent later this year…more
The 10 scariest pharma and healthcare YouTube videos. From Dose of Digital blog.
Need new sales reps? Poach.
Social Media Strategy/Execution – If you’re looking to employ social media in pharma communications/marketing, a thousand providers will tell you they can help. But who is really the best for your needs?. We’ve got the partners you need in the Impactiviti network. Contact us (stevew at impactiviti dot com, or phone at 973-947-7429) for recommendations.
Tearing up the rule book on pharma sales force compensation (from Pharmaceutical Executive). And survey says: the glory days aren’t coming back.
JUST FOR FUN
Subscribe to the Impactiviti blog via e-mail (which will bring you Impactiviti Daily – a brief of the day’s top pharma news)
Visit the Impactiviti Job Board
Sign up for the Impactiviti Connection twice-monthly e-newsletter (see sample)
Leave a Reply